BAT Science - News and Conferences

Quick Navigation

Jump to content

News and Conferences

Latest News

15 December 2016 - ‘Lung-in-the-lab’ shows e-cigarette vapour does not cause DNA damage in human cells

E-cigarette vapour does not damage DNA, even at doses 28 times that of equivalent smoke exposure.

13 December 2016 - E-cigarettes vapour does not cause DNA mutations in lab tests

Several studies have compared the impact of e-cigarette vapour with that of cigarette smoke on cells and found that vapour has little or no effect.

09 December 2016 - e-cigarettes: using vaping robots to measure the amount of vapour delivered to lung cells in the lab

New research proves that e-cigarette aerosol droplets are effectively delivered to cell surfaces in lab-based biological tests.

02 December 2016 - E-cigarettes effectively deliver nicotine

New research shows that e-cigarettes are as effective at delivering nicotine as conventional cigarettes, especially when used by experienced vapers.

29 November 2016 - Science & Technology (S&T) 2015 Report wins 'Most Impressive Public Service Initiative'

BAT has won the award for the ‘Most Impressive Public Service Initiative’ at the Global Tobacco and Nicotine Forum (GTNF) conference in Brussels.

24 November 2016 -  IONTOX and British American Tobacco announce collaboration to develop Lung-Liver-Lung model

US-based biotech company IONTOX and British American Tobacco have entered into a collaboration to develop a lung-liver-lung model with a simulated blood system to study the impact of tobacco and nicotine products on lung health.

11 October 2016 - BAT develops and applies novel test to examine vaping behaviour

Understanding vaping behaviour is an essential first step towards understanding how vaping products are being used by consumers and the potential they may have to reduce harm caused by smoking.

03 October 2016 - E-cigarette vapour is less harmful to lung cells than cigarette smoke

Recent tests conducted by scientists at British American Tobacco (BAT) show that, in stark contrast to cigarette smoke, vapour from the commercially available e-cigarette Vype ePen is less toxic to, and does not cause oxidative stress1 in, human lung cells.

19 September 2016 - Toxicant levels in Vype ePen emissions are on average 92-99% less compared to smoke

A comparison between the vapour from Vype ePen – a commercially available e-cigarette – and 3R4F – a reference cigarette – revealed substantial reductions in the e-Pen’s emissions for all toxicant groups measured.

22 July 2016 - Global standards for vaping products essential to promote innovation

Against a backdrop of a growing number of e-cigarette users globally*, British American Tobacco (BAT) is leading efforts to develop and harmonise standards around vaping products to further reassure consumers of these products potential in reducing the harm from smoking.

18 June 2016 - Advancing scientific research requires an independent, critical yet open approach

A culture of greater—not less— transparency in tobacco and tobacco-industry funded research is needed if we are to realise the reduced risk potential of e-cigarettes and other next generation products.

25 May 2016 - BAT’s appearance on BBC’s Horizon underlines its commitment to tobacco harm reduction and scientific engagement.

The impact of e-cigarettes was recently explored in BBC’s Horizon documentary, E-cigarettes: Miracle or Menace?, which concluded that e-cigarettes could benefit public health.

04 May 2016 - Utility of biomarkers of potential harm for the assessment of novel  tobacco and nicotine products.

BAT presented its experience and approach to using biomarkers to assess the reduced-risk potential of novel tobacco and nicotine products at the US Food and Drug Administration’s workshop Biomarkers of Potential Harm (April 4-5).

26 April 2016 - Acute inhalation toxicity: in vitro and ex vivo systems

BAT’s Pre-Clinical Assessment Manager, Dr Marinna Gaça, presented on Acute inhalation toxicity: in vitro and ex vivo systems in a webinar covering State-of-the-science, practical application, and dosimetry considerations for in vitro and ex vivo methods.

05 April 2016 - Regulatory bridging approach needed to keep e-cigarettes innovations coming

A regulatory mechanism that allows for a bridging approach between different variants of e-cigarettes and other next generation products is needed.

15 March 2016 - SOT - e-cig in-vitro assays

In-vitro testing of Vype vapour revealed no cell stress, DNA damage or malignant transformation.

15 March 2016 - American Chemical Society Meeting Spring 2016

BAT’s Chief Scientific Officer, Chris Proctor, is in San Diego at the Spring National Meeting of the American Chemical Society.

05 March 2016 - SRNT - i-Fuse chem profile data compared to reference cigarette

Hybrid device produces tobacco-flavoured aerosol with same characteristics as e-cigarette vapour.

03 March 2016 - Science & Technology 2015 Report

Available today, British American Tobacco’s 2015 Science & Technology Report details significant strides in the science of tobacco harm reduction made by BAT’s R&D department over the last year.

03 March 2016 - SRNT- Formaldehyde data for three formats of e-cigs

Formaldehyde exposure from three different e-cigarette formats well below WHO air quality guideline.

View more 

Recent Conferences

17 June 2016 - Global Forum on Nicotine (GFN)

04 April 2016 - FDA Workshop on Biomarkers of Potential Harm

04 April 2016 - Institute for In Vitro Sciences Workshop (IIVS)

13 March 2016 - Society of Toxicology (SOT)

2 March 2016 - Society for Research on Nicotine and Tobacco (SRNT)

27 January 2016 - Systems Toxicology - Real World Applications and Opportunities (SYTOX)

27 January 2016 - International Symposium on Capillary Chromatography (ISCC)

View recent and upcoming conferences